In December 2007, the New York Times published an article entitled "Data about Zetia risk was not fully revealed." The article claimed that Merck and Schering-Plough, the manufacturers of Zetia (aka ezetimibe), have information pertaining to the risk of liver damage when taking this cholesterol lowering medication in combination with statin drugs but that the companies have not released them to the public. The 2 companies confirm that this information exists yet justify not publishin...
Read more »...statins have the potential to cause serious side effects such as muscle injury and liver damage.... Read more »
...injury occur. Patients are advised of the risk of liver damage and are advised to call their... Read more »
...of the ENHANCE study, a trial that evaluated the effects of ezetimibe + simvastatin (aka... Read more »
...medications and supplements come with their own side effects which can make taking them very... Read more »
...cocktails or beers on the weekends without fear of liver damage? Answer: Even without... Read more »
SEATTLE (Ivanhoe Broadcast News) -- Damaged livers and diseased blood vessels are two common medical problems, but now, two new breakthroughs could... Read summary »
(Ivanhoe Newswire) New research sheds light on how a cholesterol drug works in the body. The study is significant because the drug ezetimibe (Zetia)... Read summary »
(Ivanhoe Newswire) -- A new study reveals it is generally safe to stop anti-seizure medications in children with epilepsy who have been seizure-free... Read summary »
WALDORF, Md. (Ivanhoe Broadcast News) -- Lung cancer is the leading cause of death in both men and women. Until now, the only treatment has been... Read summary »
(Ivanhoe Newswire) Researchers have discovered a regulator that could lead to new therapies for lowering unhealthy levels of cholesterol and fats.... Read summary »